Novo Nordisk A/S (NVO)
Last Price$88.15.2%
Market Cap$392.3B
Relative value
$43.0
Overvalued (Relative Value)
51.2%
NTM P/E
23.0x
Peer set median: 7.9x
1Y Fwd EV/EBITDA
17.9x
Peer set median: 7.9x
Stock quality
7/10
Good
NVO Relative Value & Intrinsic Value
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
NVO Valuation Multiples comparison vs Peer Set
Crunching data... Almost there!
NVO Valuation multiples overview
Crunching data... Almost there!
NVO Valuation multiples history vs. Peer set
Crunching data... Almost there!
Explore more intrinsic value tools hub for NVO
DCF value calculator
Peter Lynch Fair Value
Earnings Power Value
Intrinsic Value
Reverse DCF
Margin of safety
Peter Lynch charts
Earnings growth model
Ben Graham Fair Value
Discount rate
FAQ
What is Novo Nordisk A/S relative value?
As of Feb 21, 2025, Apple Relative Value is $43.0. This suggests it may be overvalued by 51.2% compared to its current price of around $88.1.
What is Novo Nordisk A/S DCF (discounted cash flow) valuation?
As of Feb 21, 2025, Novo Nordisk A/S's Discounted Cash Flow (DCF) valuation estimates its share price at $79.0. This suggests it may be overvalued by 10.3% to its current price of around $88.1, using a discount rate of 7.4% and terminal growth rate of 3.0%.
What is Novo Nordisk A/S intrinsic value?
As of Feb 21, 2025, Apple Intrinsic Value is $60.9. This suggests it may be overvalued by 30.9% compared to its current price of around $88.1.